Journal of therapeutic ultrasound

J Ther Ultrasound · ISSN (print) 2050-5736 · 9 papers in corpus
2018
2016
article 2015
doi:10.1186/2050-5736-3-s1-o95

Symptomatic localized adenomyosis is generally treated conservatively, or with more radical treatments such as hysterectomy. An effective non-invasive therapy is needed, especially for those who wish to preserve their fertility. MR-guided F…

2015
doi:10.1186/2050-5736-3-s1-p86
2014
doi:10.1186/2050-5736-2-7 ·PMID:25512868

BackgroundTo compare one-year all-cause and uterine fibroid (UF)-related direct costs in patients treated with one of the following three uterine-sparing procedures: magnetic resonance-guided focused ultrasound (MRgFUS), uterine artery embo…

article 2014
doi:10.1186/2050-5736-2-s1-a10

Background Adenomyosis is a complex disorder that accounts up to one third of gynecological morbidity. Diffuse form of adenomyosis is most difficult to diagnose and treat. All attempts to create a “gold standard” in preserving therapy have …

article 2014
doi:10.1186/2050-5736-2-3 ·PMID:25512867

OBJECTIVE: The objective of the study was to describe our early experience with a comprehensive uterine fibroid center and report our results in women seeking a second opinion for management of symptomatic uterine leiomyoma. METHODS: We per…

2013
doi:10.1186/2050-5736-1-15 ·PMID:25512860

BackgroundMagnetic resonance-guided focused ultrasound (MRgFUS) is a relatively new minimally invasive treatment, approved by the US Food and Drug Administration in 2004 for treatments of symptomatic uterine leiomyomas (fibroids). The purpo…

2013
doi:10.1186/2050-5736-1-23 ·PMID:25232480

BackgroundUterine fibroids are common among women at the reproductive age. Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a novel and a conservative treatment for symptomatic cases. The aim of the study was to evaluate the…